Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2025-12-24 @ 2:46 PM
NCT ID:
NCT03739359
Eligibility Criteria:
Inclusion Criteria:
Adult patients with positive bronchodilator responses to four actuations of albuterol (Ventolin, GSK, UK) via MDI with VHC (OptiChamber Diamond, Philips, USA) will be eligible for enrollment. A positive bronchodilator response is defined in accordance with ATS/ERS guidelines as follows: an increase in FEV1 of ≥ 12% and absolute change ≥ 200 mL from baseline.
Exclusion Criteria:
* age ≥ 90 years old;
* pregnancy;
* pulmonary exacerbation within two weeks before enrollment;
* reluctant to participate;
* inability to complete the follow-up spirometry after each bronchodilator inhalation;
* resting heart rate \> 100bpm;
* resting systolic blood pressure \> 160mmHg or diastolic blood pressure \> 110mmHg.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT03739359
Study Brief:
Protocol Section:
NCT03739359